PL3484469T3 - Kompozycje i sposoby do wzmacniania działania środków przeciwdrobnoustrojowych - Google Patents
Kompozycje i sposoby do wzmacniania działania środków przeciwdrobnoustrojowychInfo
- Publication number
- PL3484469T3 PL3484469T3 PL17827133.4T PL17827133T PL3484469T3 PL 3484469 T3 PL3484469 T3 PL 3484469T3 PL 17827133 T PL17827133 T PL 17827133T PL 3484469 T3 PL3484469 T3 PL 3484469T3
- Authority
- PL
- Poland
- Prior art keywords
- enhancing
- compositions
- effects
- methods
- antimicrobial agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/065—Diphenyl-substituted acyclic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662362082P | 2016-07-14 | 2016-07-14 | |
| PCT/IL2017/050800 WO2018011813A1 (en) | 2016-07-14 | 2017-07-13 | Compositions and methods of potentiating antimicrobials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3484469T3 true PL3484469T3 (pl) | 2024-08-19 |
Family
ID=60952228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17827133.4T PL3484469T3 (pl) | 2016-07-14 | 2017-07-13 | Kompozycje i sposoby do wzmacniania działania środków przeciwdrobnoustrojowych |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20190183914A1 (pl) |
| EP (1) | EP3484469B1 (pl) |
| CN (3) | CN109562094A (pl) |
| CA (1) | CA3068806A1 (pl) |
| DK (1) | DK3484469T3 (pl) |
| ES (1) | ES2985112T3 (pl) |
| MA (1) | MA45688A (pl) |
| PL (1) | PL3484469T3 (pl) |
| WO (1) | WO2018011813A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018528977A (ja) | 2015-09-22 | 2018-10-04 | バイタリティ バイオファーマ インコーポレイテッドＶｉｔａｌｉｔｙ Ｂｉｏｐｈａｒｍａ， Ｉｎｃ． | カンナビノイドグリコシドプロドラッグおよび合成の方法 |
| CA3063186A1 (en) | 2017-05-09 | 2018-11-15 | Vitality Biopharma, Inc. | Antimicrobial compositions comprising cannabinoids and methods of using the same |
| US12198788B2 (en) * | 2017-10-04 | 2025-01-14 | Cannibite Bvba | System for detecting an intraoral disease and determining a personalized treatment scheme and method of doing same |
| WO2020000024A1 (en) * | 2018-06-28 | 2020-01-02 | Botanix Pharmaceuticals Ltd | Antibacterial treatment using cannabinoid combinations |
| EP3846616A4 (en) * | 2018-09-05 | 2022-05-25 | Nemus Bioscience, Inc. | CANNABINOIDS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS INCLUDING ANTIBIOTIC RESISTANT BACTERIA STRAINS |
| WO2020089902A1 (en) * | 2018-10-30 | 2020-05-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compositions comprising cannabinoids for use in the treatment of biofilm and conditions associated with microbial, fungal, bacterial infections |
| GB2581987B (en) * | 2019-03-06 | 2021-11-17 | Gw Res Ltd | Use of cannabidiol in combination with antibiotics |
| US20220151982A1 (en) * | 2019-03-28 | 2022-05-19 | Scicann Therapeutics Inc. | Cannabinoid compositions and use thereof |
| CN109758441A (zh) * | 2019-03-29 | 2019-05-17 | 广东工业大学 | N-脂肪酰基乙醇胺类化合物在制备抑制细菌群体感应系统的药物中的应用和药物 |
| WO2020223811A1 (en) | 2019-05-06 | 2020-11-12 | The University Of British Columbia | Antibiotic cannabinoid-terpene formulations |
| EP3986395A4 (en) * | 2019-06-18 | 2023-08-09 | Botanix Pharmaceuticals Ltd | ANTIBACTERIAL DOSAGE REGIMEN USING CANNABINOIDS |
| WO2020263975A1 (en) | 2019-06-24 | 2020-12-30 | Diverse Biotech, Inc. | Beta-lactam-cannabinoid conjugate molecules |
| CN110973159B (zh) * | 2019-10-30 | 2021-04-06 | 广州市浪奇实业股份有限公司 | 一种含有大麻二酚的抗菌组合物及其应用 |
| BR112022010473A2 (pt) * | 2019-11-29 | 2022-09-06 | Botanix Pharmaceuticals Ltd | Tratamento antibacteriano usando um canabinoide e um agente ativo |
| CN112195558A (zh) * | 2020-09-24 | 2021-01-08 | 上海丰格无纺布有限公司 | 一种抗微生物无纺布及其制备方法 |
| WO2023130142A2 (en) * | 2022-01-03 | 2023-07-06 | Bryant Cynthia W | Compositions and methods using cannabinoid compounds for treating urinary tract disorders |
| WO2024159198A2 (en) * | 2023-01-27 | 2024-08-02 | Nagy Aurangzeb Nafees | Compositions and methods using tetrahydrocannabinol and compositions including same for treating indications involving inflammation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506224A (en) | 1991-12-31 | 1996-04-09 | Lifegroup S.P.A. | N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes |
| CA2330681C (en) | 1998-05-29 | 2008-08-26 | Andrea Giuffrida | Control of pain with endogenous cannabinoids |
| US20050054730A1 (en) | 2001-03-27 | 2005-03-10 | The Regents Of The University Of California | Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha |
| US7348338B2 (en) | 2003-07-17 | 2008-03-25 | Plexxikon, Inc. | PPAR active compounds |
| WO2009158499A2 (en) * | 2008-06-25 | 2009-12-30 | University Of North Texas Health Science Center At Fort Worth | Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems |
| WO2010013240A1 (en) | 2008-07-31 | 2010-02-04 | Dekel Pharmaceuticals Ltd. | Compositions and methods for treating inflammatory disorders |
| CN103361820A (zh) * | 2012-03-30 | 2013-10-23 | 太仓棨淂服装有限公司 | 一种抗菌牛仔面料 |
| EP3049076A4 (en) * | 2013-09-26 | 2018-04-18 | Ronald D. Sekura | Topical treatments incorporating cannabis sp. derived botanical drug product |
-
2017
- 2017-07-13 MA MA045688A patent/MA45688A/fr unknown
- 2017-07-13 CN CN201780043787.1A patent/CN109562094A/zh active Pending
- 2017-07-13 WO PCT/IL2017/050800 patent/WO2018011813A1/en not_active Ceased
- 2017-07-13 CN CN202411467744.4A patent/CN119633002A/zh active Pending
- 2017-07-13 PL PL17827133.4T patent/PL3484469T3/pl unknown
- 2017-07-13 DK DK17827133.4T patent/DK3484469T3/da active
- 2017-07-13 CA CA3068806A patent/CA3068806A1/en not_active Abandoned
- 2017-07-13 EP EP17827133.4A patent/EP3484469B1/en active Active
- 2017-07-13 ES ES17827133T patent/ES2985112T3/es active Active
- 2017-07-13 CN CN202411467740.6A patent/CN119770661A/zh active Pending
-
2019
- 2019-01-11 US US16/246,084 patent/US20190183914A1/en not_active Abandoned
-
2020
- 2020-06-09 US US16/896,701 patent/US11491172B2/en active Active
-
2022
- 2022-09-29 US US17/955,730 patent/US20230045747A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MA45688A (fr) | 2019-05-22 |
| ES2985112T3 (es) | 2024-11-04 |
| US20210093652A1 (en) | 2021-04-01 |
| EP3484469B1 (en) | 2024-05-22 |
| CN119770661A (zh) | 2025-04-08 |
| EP3484469A1 (en) | 2019-05-22 |
| CN109562094A (zh) | 2019-04-02 |
| US11491172B2 (en) | 2022-11-08 |
| CN119633002A (zh) | 2025-03-18 |
| EP3484469A4 (en) | 2020-07-22 |
| US20230045747A1 (en) | 2023-02-09 |
| CA3068806A1 (en) | 2018-01-18 |
| WO2018011813A1 (en) | 2018-01-18 |
| DK3484469T3 (da) | 2024-06-24 |
| US20190183914A1 (en) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3484469T3 (pl) | Kompozycje i sposoby do wzmacniania działania środków przeciwdrobnoustrojowych | |
| PL3443009T3 (pl) | Przeciwciała i kompozycje anty-tim-3 | |
| EP3419676A4 (en) | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | |
| EP3534968A4 (en) | ANTI-BCMA T CAR LYMPHOCYTE COMPOSITIONS | |
| DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
| PT3355990T (pt) | Compostos semifluorados e as suas composições | |
| EP3478308A4 (en) | CANNABIS-BASED COMPOSITION AND PROCESSES | |
| DK3416996T3 (da) | Hærdelig sammensætning | |
| PL3277270T3 (pl) | Kompozycje i sposoby leczenia niedokrwistości | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| EP3310376A4 (en) | MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF | |
| EP3250367A4 (en) | ACTIVE CALIBRATION | |
| DK3494119T3 (da) | Forbindelser og sammensætninger og anvendelser deraf | |
| EP3464424A4 (en) | PAI-BASED COATING COMPOSITIONS | |
| EP3415008A4 (en) | GERMIC COMPOSITION | |
| PT3261437T (pt) | Compostos e composições fungicidas | |
| EP3380471A4 (en) | COMT-INHIBITORY METHOD AND COMPOSITION | |
| EP3412344A4 (en) | FIRE-DELAYING COMPOSITION | |
| EP3500102C0 (en) | ANTIMICROBIAL COMPOSITION | |
| EP3443078A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
| MA50787A (fr) | Compositions fongicides | |
| SI3573620T1 (sl) | Sestavki za zdravljenje hipertenzije | |
| DK3562921T3 (da) | Smøremiddelsammensætning indbefattende n-alkyleret dianilin | |
| DK3451829T3 (da) | Antimikrobielle sammensætninger | |
| IL264445A (en) | Compounds and compositions and uses thereof |